Dobbs T

Evaluation of the performance of three biomarker assays for recent HIV infection using a well-characterized HIV-1 subtype C incidence cohort
Gonese E, Kilmarx PH, van Schalkwyk C, Grebe PE, Mutasa K, Ntozini R, Parekh BS, Dobbs T, Pottinger YD, Masciotra S, Owen M, Nachega JB, van Zyl G, Hargrove JW

AIDS Research And Human Retroviruses

(2019)

https://doi.org/10.1089/aid.2019.0033
Heightened HIV antibody responses in postpartum women as exemplified by recent infection assays: implications for incidence estimates
Hargrove JW, van Schalkwyk C, Humphrey JH, Mutasa K, Ntozini R, Owen SM, Masciotra S, Parekh BS, Duong YT, Dobbs T, Kilmarx PH, Gonese E

AIDS Research And Human Retroviruses

(2017)

https://doi.org/10.1089/aid.2016.0319
Recalibration of the limiting antigen avidity eia to determine mean duration of recent infection in divergent HIV-1 subtypes
Duong YT, Kassanjee R, Welte A, Morgan M, De A, Dobbs T, Rottinghaus E, Nkengasong J, Curlin ME, Kittinunvorakoon C, Raengsakulrach B, Martin M, Choopanya K, Vanichseni S, Jiang Y, Qiu M, Yu H, Hao Y, Shah N, Le L-V, Kim AA, Nguyen TA, Ampofo W, Parekh BS

PLOS ONE

(2015)

https://doi.org/10.1371/journal.pone.0114947
Determination of mean recency period for estimation of HIV type 1 Incidence with the BED-capture EIA in persons infected with diverse subtypes
Parekh BS, Hanson DL, Hargrove JW, Branson B, Green T, Dobbs T, Constantine N, Overbaugh J, McDougal JS

AIDS Research And Human Retroviruses

(2011)

https://doi.org/10.1089/aid.2010.0159